Amundi Horizon Therapeutics Public LTD CO Transaction History

Amundi

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $21.1 Million - $24.7 Million	213,350 Added 55.06%	600,815 $69.5 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $8.97 Million - $10.5 Million	93,064 Added 31.61%	387,465 $39.9 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $1.08 Million - $1.14 Million	10,052 Added 3.54%	294,401 $32.1 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $482,524 - $880,129	7,734 Added 2.8%	284,349 $32.4 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $7.37 Million - $10.6 Million	125,012 Added 82.46%	276,615 $18.5 Million

Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $994,961 - $1.46 Million	-12,531 Reduced 7.63%	151,603 $12 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $939,471 - $1.19 Million	-10,871 Reduced 6.21%	164,134 $18.4 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $1.63 Million - $1.99 Million	-16,573 Reduced 8.65%	175,005 $15.8 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $2.36 Million - $2.83 Million	-25,667 Reduced 11.81%	191,578 $21 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $18.7 Million - $20.8 Million	217,245 New	217,245 $20.3 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.